Univest
Univest
  • Markets

Sigachi Industries Ltd. (SIGACHI): Sigachi Industries Share Price Rises 8.33% Today; Stock in Focus

  • August 20, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Sigachi Industries Share Price

Sigachi Industries Ltd. traded at Rs 31.2, up 8.33% today, taking its market capitalisation to Rs 1,133.36 crore and placing the small-cap stock among notable gainers.

Sigachi Industries Share Price moved sharply higher on 20 August 2026, with the stock trading at Rs 31.2, up Rs 2.4 or 8.33% from the previous close of Rs 28.8. At that price, the company’s market capitalisation stood at Rs 1,133.36 crore. In Stock Market Today terms, that makes Sigachi Industries one of the more visible small-cap names in Healthcare, especially within the Pharmaceuticals & Drugs industry.

The verified data confirms a clear same-day price rise and shows why the stock is trending in Share Market Today conversations. The move was accompanied by total traded volume of 30,61,039 shares across exchanges, including 2,810,216 shares on NSE and 250,823 shares on BSE, while BSE turnover stood at Rs 0.78 crore. The stock opened at Rs 29.94, slipped to an intraday low of Rs 29, and then climbed to Rs 31.35, leaving it close to the day’s high at the time of the article.

Why is it rising today? The supplied data confirms the price event and unusually active trading, but it does not establish a company-specific catalyst. What investors can verify immediately is that Sigachi Industries Share Price has recorded a meaningful gain for a Small Cap stock, that valuation sits above the industry median on earnings, and that profitability ratios remain notably higher than industry benchmarks. For readers tracking Sigachi Industries Stock News, the next things to monitor are whether price action holds near the intraday high, how the stock compares with listed pharmaceutical peers, and whether fundamentals continue to justify investor attention. Univest is tracking the move through a price, sector and peer lens rather than speculation.

Sigachi Industries Ltd. (SIGACHI) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 31.2
Previous Close Rs 28.8
Today's Change +Rs 2.4 (+8.33%)
Day Open Rs 29.94
Day High Rs 31.35
Day Low Rs 29
Current Volume (BSE) 2,50,823
BSE Traded Volume 2,50,823
NSE Traded Volume 28,10,216
Combined NSE + BSE Volume 30,61,039
Turnover Rs 0.78 crore
Market Capitalisation Rs 1,133.36 crore
Market Cap Category Small Cap

Sigachi Industries Ltd. (SIGACHI) traded at Rs 31.2. versus the previous close of Rs 28.8, a rise of 8.33%. The stock opened at Rs 29.94, reached Rs 31.35, touched Rs 29. Reported volume was 2,50,823.

Sigachi Industries Ltd. (SIGACHI) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,133.36 crore
P/E Ratio 43.41x
P/B Ratio 2.08x
ROE 38.11%
ROCE 37.83%
EPS Rs 0.66
Dividend Yield 0%

Sigachi Industries Ltd. was valued at a P/E ratio of 43.41x, a P/B ratio of 2.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 38.11% and ROCE of 37.83%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 0.66, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sigachi Industries Fundamental Analysis starts with the company’s size and valuation. At the current price, the company has a market capitalisation of Rs 1,133.36 crore. Its P/E ratio is 43.41 and its P/B ratio is 2.08. Those are not standalone conclusions by themselves, but they provide useful context for why the stock attracts attention when price action turns strong. The earnings multiple of 43.41 places the stock above the industry median P/E of 24.91 and also above the industry average of 39.72, which suggests the market is valuing Sigachi Industries Share Price at a premium to the typical same-industry company on earnings.

Profitability metrics are stronger than that valuation might initially imply. ROE stands at 38.11% and ROCE at 37.83%, both materially above the Pharmaceuticals & Drugs benchmark median figures of 10.49% and 12.97%, and also above the benchmark averages of 8.1% and 15.53%. That gap is important in financial analysis because it shows that the company’s return ratios are significantly stronger than broad industry reference points available in the supplied data.

EPS is Rs 0.66, which indicates the earnings attributable to each share based on the supplied dataset. Dividend yield is 0, meaning the current data does not reflect an ongoing yield support in the stock’s valuation profile. That can matter for investors comparing Sigachi Industries Share Price with other healthcare names where dividends contribute a part of total shareholder return history.

The P/B ratio of 2.08 sits above the industry median of 1.87 but below the industry average of 2.47, placing the stock somewhere between median and mean sector valuation on a book basis. Put differently, the earnings multiple looks more elevated than the book multiple when read against the benchmark. For readers following Sigachi Industries Stock News and Sigachi Industries Financial Results trends, the key fundamental takeaway from Univest is that the share price rise is occurring in a stock with high reported return ratios, but also with an above-median earnings valuation. That mix keeps the stock interesting without turning the analysis into a recommendation.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 43.41x
Benchmark Median P/E 24.91x
Benchmark Average P/E 39.72x
Benchmark P/E Range 2.76x to 357.74x
Company P/B Ratio 2.08x
Benchmark Median P/B 1.87x
Company ROE 38.11%
Benchmark Median ROE 10.49%
Company ROCE 37.83%
Benchmark Median ROCE 12.97%
Company Market Capitalisation Rs 1,133.36 crore
Benchmark Median Market Cap Rs 140.77 crore

Sigachi Industries Ltd. (SIGACHI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Sigachi Industries Ltd. (SIGACHI) has a P/E ratio of 43.41x, which is above the benchmark median of 24.91x, a difference of +74.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sigachi Industries Ltd. (SIGACHI) has a ROE of 38.11%, which is above the benchmark median of 10.49%, a difference of +263.3%. Sigachi Industries Ltd. (SIGACHI) has a ROCE of 37.83%, which is above the benchmark median of 12.97%, a difference of +191.67%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Sigachi Industries Share Price is moving within the Healthcare sector and, more specifically, the Pharmaceuticals & Drugs industry. Against the supplied same-industry benchmark of 136 companies, the stock sits in a part of the market where valuation spreads are wide, profitability varies sharply, and market capitalisations range from very small to multi-thousand-crore businesses. That sector context helps explain why a single-day price rise can quickly draw broader interest.

The industry benchmark shows company P/E at 43.41 for Sigachi Industries versus a median of 24.91 and an average of 39.72, based on 105 companies with P/E data. The benchmark range is wide, from 2.76 to 357.74, so the stock is not near the extreme top of the range, but it is still priced above both the median and average on earnings. On P/B, Sigachi Industries stands at 2.08 versus a median of 1.87 and an average of 2.47 across 135 companies. That means the stock is only modestly above the median and below the average on book-value valuation.

Profitability tells a different story. Company ROE is 38.11% against an industry median of 10.49% and average of 8.1%. Company ROCE is 37.83% against an industry median of 12.97% and average of 15.53%. These are large gaps and they make the stock stand out positively on return metrics relative to the same-industry benchmark. In market-cap terms, Sigachi Industries at Rs 1,133.36 crore is well above the benchmark median of Rs 140.77 crore and above the average of Rs 491.98 crore, though still below the benchmark maximum of Rs 3,012.78 crore.

For Sigachi Industries Market Cap and valuation watchers, the sector picture is therefore mixed but useful: the stock trades at a premium to median earnings multiples, yet its profitability ratios are also substantially stronger than benchmark norms. Univest views that combination as one reason the stock remains relevant in NSE News, BSE News and broader Indian Stock Market screens when price action improves.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Ind-Swift Laboratories Ltd. INDSWFTLAB 3,012.78 48.9 1.87 -0.78 8.31
Hikal Ltd. HIKAL 2,679.94 0 2.22 15.22 16.15
Dishman Carbogen Amcis Ltd. DCAL 2,648.85 167.12 0.41 -2.89 -0.26
Solara Active Pharma Sciences Ltd. SOLARA 2,641.96 0 2.08 17.23 15.34
Beta Drugs Ltd. BETA 2,610.72 64.32 10.17 18.65 22.17

Sigachi Industries Ltd. (SIGACHI) has a P/E ratio of 43.41x compared with the displayed peer median of 48.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 38.11% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 37.83% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Sigachi Industries Ltd. (SIGACHI) has a market capitalisation of Rs 1,133.36 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Sigachi Industries Share Price also becomes easier to assess when placed beside listed Pharmaceuticals & Drugs peers. Within the supplied peer set, Sigachi Industries has a market capitalisation of Rs 1,133.36 crore, which is smaller than Ind-Swift Laboratories at Rs 3,012.78 crore, Hikal at Rs 2,679.94 crore, Dishman Carbogen Amcis at Rs 2,648.85 crore, Solara Active Pharma Sciences at Rs 2,641.96 crore and Beta Drugs at Rs 2,610.72 crore. So while Sigachi is not among the largest peers shown, it is clearly operating in a listed comparison set populated by companies with larger market values.

On valuation, Sigachi’s P/E of 43.41 is lower than Ind-Swift Laboratories at 48.9, much lower than Dishman Carbogen Amcis at 167.12 and Beta Drugs at 64.32, but higher than Venus Remedies at 20.4 and Hester Biosciences at 15.06. That places the company somewhere in the middle of the peer earnings-valuation spread rather than at an extreme. Its P/B of 2.08 is equal to Solara Active Pharma Sciences, below Beta Drugs at 10.17, Fredun Pharmaceuticals at 8.03, Hester Biosciences at 4.51 and Venus Remedies at 3.45, and slightly above Ind-Swift Laboratories at 1.87 and Hikal at 2.22.

The sharper distinction appears in return ratios. Sigachi’s ROE of 38.11% is comfortably above Hikal’s 15.22%, Solara’s 17.23%, Beta Drugs’ 18.65%, Venus Remedies’ 9.85%, Fredun Pharmaceuticals’ 11.42% and Hester Biosciences’ 16.17%. It is also far ahead of Ind-Swift Laboratories at -0.78% and Dishman Carbogen Amcis at -2.89%. ROCE at 37.83% shows a similar pattern, exceeding Beta Drugs at 22.17%, Hikal at 16.15%, Solara at 15.34%, Fredun at 13.15%, Sai Parenteral’s at 12.97% and Hester Biosciences at 14.12%.

That peer picture suggests that Sigachi Industries Share Price is not simply a case of a richly valued small-cap stock without operating support. Relative to this peer set, the company combines a mid-range P/E with one of the strongest ROE and ROCE profiles in the group. Univest therefore sees the stock’s current attention as rooted in both price action and comparative profitability.

Why Investors Are Watching Sigachi Industries

Sigachi Industries Share Price is in focus because today’s move combines visible market action with a financial profile that stands out in parts of the listed pharmaceutical universe. The stock has logged an 8.33% gain, traded close to its intraday high and recorded total volume of 30,61,039 shares across BSE and NSE. At the same time, its profitability metrics compare favourably with both benchmark industry statistics and several listed peers, even though the earnings multiple is above the industry median.

  • Verified price action: the stock rose from Rs 28.8 to Rs 31.2, after opening at Rs 29.94 and touching Rs 31.35.
  • Volume participation: total traded volume reached 30,61,039 shares, with 2,810,216 on NSE and 250,823 on BSE.
  • Fundamental context: P/E is 43.41, P/B is 2.08, ROE is 38.11% and ROCE is 37.83%.
  • Sector positioning: earnings valuation is above the industry median, while return ratios are well above industry medians and averages.
  • Peer standing: profitability compares strongly with peers such as Hikal, Solara, Beta Drugs and Venus Remedies.

What should investors monitor next? The practical watchpoints are whether Sigachi Industries Share Price holds near today’s upper range, whether active trading remains broad-based across exchanges, and whether the stock’s premium-to-median P/E continues to be balanced by superior ROE and ROCE. Univest also sees sector-relative valuation and peer comparisons as important reference points for any follow-up move.

About Sigachi Industries

Sigachi Industries Ltd. is part of the Healthcare sector and operates within the Pharmaceuticals & Drugs industry. Even with limited business-description fields in the supplied dataset, that classification alone is meaningful because it places the company in a regulated and closely followed listed segment of the Indian stock market where valuation, profitability and scale can differ substantially from one company to another.

In the current same-industry benchmark, the company sits among 136 listed businesses, with market capitalisations ranging from Rs 5.94 crore to Rs 3,012.78 crore. Sigachi Industries, at Rs 1,133.36 crore, stands above the industry median market capitalisation of Rs 140.77 crore and also above the average of Rs 491.98 crore. That indicates it is not one of the smallest names in the space, even though it is still classified as a small-cap company in market terms.

Its industry context also matters for how investors read Sigachi Industries Share News. Pharmaceutical and healthcare counters are often evaluated using a mix of market cap, earnings multiples and return ratios. In that framework, Sigachi Industries currently shows a P/E of 43.41, P/B of 2.08, ROE of 38.11% and ROCE of 37.83%. Those numbers give the market a clearer snapshot of how the company is being valued and how efficiently it is generating returns relative to capital. For readers of Sigachi Industries Latest News, the most reliable way to understand the company today is through this intersection of sector classification, market size and financial metrics.

Track Sigachi Industries Share Price on Univest

Use Sigachi Industries Ltd. (SIGACHI) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who want to follow Sigachi Industries Share Price more closely can track the stock on Univest for live price movement, market-cap changes, valuation ratios and broader stock analysis. A single dashboard view helps users watch Sigachi Industries Share Price Today alongside day high, day low, previous close and exchange-wise trading activity across NSE and BSE.

Univest also helps readers place Sigachi Industries Stock News in context by showing fundamental ratios such as P/E, P/B, ROE, ROCE, EPS and dividend yield, along with peer and sector comparisons where available. For those tracking Stocks Rising Today and daily market movers, Univest offers a practical way to monitor shareholding patterns, 52-week levels, technical indicators when supplied, and market insights without turning market data into an investment recommendation.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why is Sigachi Industries Share Price rising today?

Ans. Sigachi Industries Share Price rose 8.33% to Rs 31.2 from the previous close of Rs 28.8. The supplied data confirms the price rise and active trading volumes, but it does not establish a company-specific catalyst for today’s move.

What is Sigachi Industries Share Price Today?

Ans. Sigachi Industries Share Price Today is Rs 31.2 at the time of the article. That reflects a gain of Rs 2.4 in one session, with the stock trading between Rs 29 and Rs 31.35 during the day.

How much did Sigachi Industries stock gain in today’s trade?

Ans. Sigachi Industries stock gained Rs 2.4 or 8.33% versus the previous close of Rs 28.8. The move also placed the stock among notable small-cap gainers, with trading activity recorded across both NSE and BSE.

What was the day high and day low for Sigachi Industries?

Ans. The stock touched an intraday high of Rs 31.35 and an intraday low of Rs 29. It opened at Rs 29.94 and later traded at Rs 31.2, which kept the price close to the upper end of the session range.

What is the market capitalisation of Sigachi Industries?

Ans. Sigachi Industries has a market capitalisation of Rs 1,133.36 crore based on the supplied data. That places it in the Small Cap category and above the industry median market capitalisation of Rs 140.77 crore.

Is Sigachi Industries expensive compared with its industry on P/E?

Ans. Sigachi Industries trades at a P/E of 43.41. That is above the Pharmaceuticals & Drugs industry median of 24.91 and also above the industry average of 39.72, indicating a higher-than-median earnings valuation.

How does Sigachi Industries compare on profitability?

Ans. The company reports ROE of 38.11% and ROCE of 37.83%. Both are well above the same-industry median figures of 10.49% and 12.97%, showing materially stronger profitability than broad benchmark levels.

What is the P/B ratio of Sigachi Industries?

Ans. Sigachi Industries has a P/B ratio of 2.08. That is slightly above the industry median of 1.87 but below the industry average of 2.47, placing the stock in a moderate position on book-value valuation.

How strong was trading volume in Sigachi Industries today?

Ans. Total traded volume in Sigachi Industries reached 30,61,039 shares. Of this, 2,810,216 shares were traded on NSE and 250,823 shares on BSE, while reported BSE turnover stood at Rs 0.78 crore.

What do EPS and dividend yield show for Sigachi Industries?

Ans. Sigachi Industries has an EPS of Rs 0.66, which reflects earnings attributable to each share in the supplied data. Its dividend yield is 0, so the current dataset does not show any yield support at this price.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply